M. Reynaud-Gaubert

973 total citations
37 papers, 206 citations indexed

About

M. Reynaud-Gaubert is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Epidemiology. According to data from OpenAlex, M. Reynaud-Gaubert has authored 37 papers receiving a total of 206 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 18 papers in Surgery and 7 papers in Epidemiology. Recurrent topics in M. Reynaud-Gaubert's work include Transplantation: Methods and Outcomes (14 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers) and Cystic Fibrosis Research Advances (7 papers). M. Reynaud-Gaubert is often cited by papers focused on Transplantation: Methods and Outcomes (14 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers) and Cystic Fibrosis Research Advances (7 papers). M. Reynaud-Gaubert collaborates with scholars based in France, United Kingdom and United States. M. Reynaud-Gaubert's co-authors include P. Thomas, P. Fuentès, Jean‐Marc Rolain, Carine Gomez, C. Gomez, M Noirclerc, Laurent Mély, Romain Kessler, Jean Michel Bartoli and Marion Faucher and has published in prestigious journals such as European Respiratory Journal, Transplantation and American Journal of Roentgenology.

In The Last Decade

M. Reynaud-Gaubert

33 papers receiving 196 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Reynaud-Gaubert France 10 128 77 32 23 20 37 206
Janne Kaes Belgium 8 59 0.5× 86 1.1× 29 0.9× 27 1.2× 17 0.8× 25 150
Damian McKeon United Kingdom 6 168 1.3× 59 0.8× 49 1.5× 8 0.3× 23 1.1× 13 217
J.-M. Lalot France 7 49 0.4× 57 0.7× 7 0.2× 5 0.2× 31 1.6× 13 167
Emily Clausen United States 9 84 0.7× 79 1.0× 37 1.2× 27 1.2× 12 0.6× 21 175
Sadi Marcelo Schio Brazil 11 111 0.9× 140 1.8× 102 3.2× 42 1.8× 5 0.3× 21 273
V. Linacre Canada 5 30 0.2× 163 2.1× 15 0.5× 45 2.0× 25 1.3× 14 221
Y.H. Kim South Korea 10 40 0.3× 236 3.1× 52 1.6× 50 2.2× 53 2.6× 21 357
İlker Turan Türkiye 10 54 0.4× 111 1.4× 42 1.3× 5 0.2× 28 1.4× 38 235
Alejandro Bertolotti Argentina 9 39 0.3× 125 1.6× 115 3.6× 23 1.0× 15 0.8× 41 279
Grossman Ra United States 8 196 1.5× 124 1.6× 9 0.3× 43 1.9× 26 1.3× 9 291

Countries citing papers authored by M. Reynaud-Gaubert

Since Specialization
Citations

This map shows the geographic impact of M. Reynaud-Gaubert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Reynaud-Gaubert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Reynaud-Gaubert more than expected).

Fields of papers citing papers by M. Reynaud-Gaubert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Reynaud-Gaubert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Reynaud-Gaubert. The network helps show where M. Reynaud-Gaubert may publish in the future.

Co-authorship network of co-authors of M. Reynaud-Gaubert

This figure shows the co-authorship network connecting the top 25 collaborators of M. Reynaud-Gaubert. A scholar is included among the top collaborators of M. Reynaud-Gaubert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Reynaud-Gaubert. M. Reynaud-Gaubert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bermudez, Julien, Xavier Heim, Benjamin Coiffard, et al.. (2025). CD146: a promising target in respiratory diseases. European Respiratory Review. 34(177). 240228–240228.
2.
Carlier, François, Bruno Detry, Jérôme Ambroise, et al.. (2025). Impaired IgA mucosal immunity following lung transplantation: a potential trigger for bronchiolitis obliterans syndrome. European Respiratory Journal. 66(5). 2402212–2402212.
3.
Brosseau, Carole, Richard Danger, Philippe Lacoste, et al.. (2019). Blood CD9+ B cell, a biomarker of bronchiolitis obliterans syndrome after lung transplantation. American Journal of Transplantation. 19(11). 3162–3175. 13 indexed citations
4.
Roussel, Arnaud, B. Renaud-Picard, Antoine Roux, et al.. (2018). Donor Club Cell Secretory Protein G38A Polymorphism Is Associated With a Decreased Risk of Primary Graft Dysfunction in the French Cohort in Lung Transplantation. Transplantation. 102(8). 1382–1390. 2 indexed citations
5.
6.
Bittar, Fadi, M. Reynaud-Gaubert, Laurent Mély, et al.. (2013). Pandoraea pulmonicola chronic colonization in a cystic fibrosis patient, France. New Microbes and New Infections. 1(2). 27–29. 13 indexed citations
7.
David, Matthias, et al.. (2011). Devenir respiratoire à l’âge adulte de la prématurité et de la dysplasie bronchopulmonaire. Revue des Maladies Respiratoires. 28(10). 1329–1339. 4 indexed citations
8.
Gomez, C. & M. Reynaud-Gaubert. (2010). Résultats à long terme de la greffe pulmonaire. Revue de Pneumologie Clinique. 67(1). 64–73. 7 indexed citations
9.
Burgel, Pierre‐Régis, Isabelle Fajac, D. Hubert, et al.. (2009). Non‐classic cystic fibrosis associated with D1152H CFTR mutation. Clinical Genetics. 77(4). 355–364. 25 indexed citations
10.
Reynaud-Gaubert, M., et al.. (2009). Les antagonistes des récepteurs de l’endothéline : leur place dans les maladies pulmonaires. Revue des Maladies Respiratoires. 26(10). 1075–1090. 1 indexed citations
11.
Reynaud-Gaubert, M., et al.. (2008). Quand le pneumologue doit-il envisager la greffe pulmonaire pour un de ses patients adulte ? Indications, critères de sélection, préparation à la greffe. Revue des Maladies Respiratoires. 25(10). 1251–1259. 9 indexed citations
12.
Bittar, Fadi, Hervé Richet, J.‐C. Dubus, et al.. (2008). Molecular detection of multiple emerging pathogens in sputa from cystic fibrosis patients. Journal of Cystic Fibrosis. 7. S41–S41. 4 indexed citations
13.
Fajac, Isabelle, F. Counil, & M. Reynaud-Gaubert. (2007). Explorations fonctionnelles respiratoires du grand enfant ou de l’adulte atteint de mucoviscidose. Revue de Pneumologie Clinique. 63(6). 367–372.
14.
Counil, François, C. Karila, Muriel Le Bourgeois, et al.. (2007). Mucoviscidose : du bon usage des explorations fonctionnelles respiratoires. Revue des Maladies Respiratoires. 24(6). 691–701.
15.
Gaubert, Jean‐Yves, Bruno Chetaille, F. Rétornaz, et al.. (2004). « Classification 2002 des pneumopathies interstitielles idiopathiques ». La Revue de Médecine Interne. 25(12). 891–905. 2 indexed citations
16.
Cracowski, Jean‐Luc, A. Yaïci, Olivier Sitbon, et al.. (2004). Évaluation pronostique de biomarqueurs dans l’hypertension artérielle pulmonaire. Revue des Maladies Respiratoires. 21(6). 1137–1143. 13 indexed citations
17.
Mamessier, Émilie, et al.. (2003). Study of cytokine gene expression in small cell samples: use in induced sputum. Journal of Immunological Methods. 280(1-2). 37–47. 5 indexed citations
18.
Reynaud-Gaubert, M., Christophe Pison, M. Stern, et al.. (2000). [Indications for lung and heart -lung transplantation in adults. SPLF-SCTCVLF-EFG-AFLM Lung Transplantation Group].. PubMed. 17(6). 1119–32. 7 indexed citations
19.
Reynaud-Gaubert, M., et al.. (2000). Indications de la transplantation pulmonaire et cardio-pulmonaire chez l'adulte. Revue des Maladies Respiratoires. 17(6). 6 indexed citations
20.
Thomas, P., et al.. (1993). Anastomotic stenosis of the left pulmonary artery after lung transplantation: treatment by percutaneous placement of an endoprosthesis.. American Journal of Roentgenology. 161(5). 947–949. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Janne Kaes Breakdown of academic impact, for papers by Damian McKeon Breakdown of academic impact, for papers by J.-M. Lalot Breakdown of academic impact, for papers by Emily Clausen Breakdown of academic impact, for papers by Sadi Marcelo Schio Breakdown of academic impact, for papers by V. Linacre Breakdown of academic impact, for papers by Y.H. Kim Breakdown of academic impact, for papers by İlker Turan Breakdown of academic impact, for papers by Alejandro Bertolotti Breakdown of academic impact, for papers by Grossman Ra
Rankless by CCL
2026